HLA-A and neoplasm: We observed that patients with low HLA-I (i.e., β2m, HLA-A, -B, and -E) expression and high levels of the CD56dim NK signature in the tumour tissue had better survival probability compared to the patients with a low CD56dim NK cell signature and high HLA-I expression (Figure 4B).